Top Analyst Reports for JPMorgan, Johnson & Johnson & Mastercard
Ahead of the market open, investors weigh the morning’s economic releases for that day’s trading. JPMorgan shares are up 12.2% year to date versus the industry gain of 13.4%. Johnson & Johnson expects faster second-half sales in both segments, with pipeline advances offset by the Stelara patent cliff and softer Abiomed expectations. Mastercard growth hinges on cross-border and contactless payments and value-added services like cybersecurity, analytics and digital authentication. Comstock Holding Companies’ first-half 2026 revenues rose 56% and